ConductScience.org, home
PVR: PVR cell adhesion molecule
API referenceFor AI assistants

Gene · 5817

Papers4,420

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

161 to 180 of 4,420

Download this page as JSON
TitleJournalYearPMIDFound bySource
TriCON: A Carbon-Based Triple-Modal Nanoplatform for Pancreatic Cancer Therapy.Adv Sci (Weinh)202641549285PubTator, text miningPubMed
From post-war reconstruction to the twenty-first century - ophthalmic pathology in Freiburg 1945-2015. Part 2: review of 43,169 histological diagnoses from 39,256 specimens collected over 71 years at a large German tertiary eye care centre.
BMC Ophthalmol202641545984PubTator, text miningPubMed
Effectiveness of poliovirus environmental surveillance in Ghana: an indicator-based performance evaluation across seven regions, 2018-2022.BMJ Open202641545053PubTator, text miningPubMed
Effect of Right Ventricular Outflow Tract Material Properties on Simulated Transcatheter Pulmonary Placement.ArXiv202641542163PubTator, text miningPubMed
On the mixed-model analysis of covariance in cluster-randomized trials.Stat Sci202641541796PubTator, text miningPubMed
Single-cell and multi-omic characterization of ex vivo expanded ASTRLs from stable kidney transplant recipients reveals a regulatory T cell phenotype.Sci Rep202641535376PubTator, text miningPubMed
Circulating T-lymphocyte subsets as biomarkers for immune checkpoint inhibitors in solid tumors.Clin Exp Immunol202641530915PubTator, text miningPubMed
A TGFB2/TNF-induced in vitro model of proliferative vitreoretinopathy (PVR) using ARPE-19 cells confirms nicotinamide as an inhibitor of EMT and VEGFA secretion.PLoS One202641529022PubTator, text miningPubMed
MHC-II vaccine ignites cold tumors while lighting up TIGIT as a compensatory brake.Med202641519118PubTator, text miningPubMed
Vital signs as biomarkers of early clinical deterioration in pediatric emergency departments: physiology, interpretation, and innovations: a narrative review.Int J Emerg Med202641501643PubTator, text miningPubMed
Adhesive bioactive materials in ocular applications: Toward smart, regenerative, and minimally invasive therapies.Bioact Mater202641492365PubTator, text miningPubMed
Neutralizing human monoclonal antibodies to poliovirus map to the receptor binding site.Nat Commun202641484135PubTator, text miningPubMed
OPN Promotes Hepatocellular Carcinoma Progression Through the p65/c-Myc/CD155 Axis by Suppressing CD8+ T Cell Infiltration and Activation.Immunol Invest202641416769PubTator, text miningPubMed
Molecular basis of CD155-mediated immune regulation revealed by a novel epitope-specific human monoclonal antibody.Int J Biol Macromol202641380899PubTator, text miningPubMed
Nectin-4 reduces T cell effector function and is a therapeutic target in pancreatic cancer.JCI Insight202641364531PubTator, text miningPubMed
Quantitative spatial profiling of PD-1/PD-L1 and TIGIT/CD155 interaction indicates poor survival outcome and resistance to adjuvant chemotherapy in pancreatic adenosquamous carcinoma.Eur J Cancer202641337905PubTator, text miningPubMed
MHC-II-restricted neoantigen vaccine reverses immune microenvironment and overcomes resistance to immune-checkpoint inhibitors in cold tumors.Med202641308654PubTator, text miningPubMed
An evolutionary T119R substitution in the macaque T-cell immunoreceptor TIGIT enables proteolytic shedding and reveals clinical antibody vulnerabilities.J Biol Chem202641274505PubTator, text miningPubMed
Loss of cyclin C drives resistance to anti-TIGIT therapy by upregulating CD155-mediated immune evasion.Drug Resist Updat202641265176PubTator, text miningPubMed
A comprehensive analysis of immune checkpoint receptor-ligand pairs in aortic diseases highlights the immunosuppressive roles of CD155 and CD274.Genes Dis202641216502PubTator, text miningPubMed

gene-search-2026-11-11-0.2.0

Previous pageNext page

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/5817/papers?page=9

API referenceFor AI assistants